Micro Labs Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: Micro Labs Limited Moxifloxacin Export Records India — #4 Exporter, 86 Shipments, $2.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Micro Labs Limited — Moxifloxacin Exporter #4 | $2.3M Trade Value | TransData Nexus | TransData Nexus

Micro Labs Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Moxifloxacin · $2.3M export value · DGFT Verified

Micro Labs Limited is the #4 Indian exporter of Moxifloxacin with $2.3M in export value and 86 verified shipments. Micro Labs Limited holds a 7.0% market share in Moxifloxacin exports across 14 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.

Micro Labs Limited — Moxifloxacin Export Profile: Buyers & Destinations

Micro Labs Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Micro Labs Limited Export Moxifloxacin?

Country	Value	Shipments	Share
THAILAND	$693.8K	15	35.3%
NIGERIA	$411.6K	10	21.0%
GERMANY	$326.7K	19	16.6%
UNITED KINGDOM	$115.8K	3	5.9%
UNITED ARAB EMIRATES

Who Are the Top Buyers of Moxifloxacin from Micro Labs Limited?

Buyer	Country	Value	Orders
MAXIM INTER-CORPORATION LTD	THAILAND	$290.5K	6
MICRO NOVA PHARMACEUTICALS IND	NIGERIA	$284.0K	6
MAXIM INTER-CORPORATION LTD.	THAILAND	$253.3K	6
MSK PHARMALOGISTIC GMBH	GERMANY	$214.7K	11
MAXIM INTER-CORPORATION LIMITED	THAILAND	$150.0K	3
MICROSYNERGY PHARMACEUTICALS FZCO	UNITED ARAB EMIRATES	$100.0K	2
COIMPORTEX SERVICIOS ADUANALES S.C.	MEXICO	$80.2K	4
BROWN AND BURK UK LIMITED	UNITED KINGDOM	$79.0K	2
MICRO NOVA PHARMACEUTICALS IND. LTD	NIGERIA	$77.5K	3
MSK PHARMALOGISTIC GMBH.	GERMANY	$62.0K	7

Micro Labs Limited supplies Moxifloxacin to 31 buyers globally. The largest buyer is MAXIM INTER-CORPORATION LTD (THAILAND), followed by MICRO NOVA PHARMACEUTICALS IND (NIGERIA) and MAXIM INTER-CORPORATION LTD. (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does Micro Labs Limited Export?

Product Description / Formulation	Value	Shipments
MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI	$195.4K	5
MICROMOX 400 (MOXIFLOXACIN 400MG TABLETS	$134.0K	3
MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTION USP 0.5% w/v) (5ML) - TAX INVOICE NO:714201272 DT: 20.03.2025	$100.0K	2
MOXI-MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI	$98.4K	2
MICROMOX EYE DROPS (MOXIFLOXACIN OPHTHALMIC SOLUTION 0% W/V)(5ML)(QTY-71550)PCS	$77.5K	3
MOXIFLOXACIN (AS HYDROCHLORIDE) 0.5% W/V	$50.0K	1
MOXI MAC ( (Moxifloxacin Ophthalmic Solu	$50.0K	1
MOXI MAC(MOXIFLOXACIN OPHTHALMIC SOLUTIO	$50.0K	1
MICROMOX EYE DROPS (MOXIFLOXACIN OPHTHAL	$50.0K	1
ACTIFLOX MOXIFLOXACIN TABLETS 400MG 5X1X5'SQTY- 7734.00019DRAWBACK	$50.0K	1

Micro Labs Limited exports 60 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MOXI MAC (MOXIFLOXACIN OPHTHALMIC SOLUTI with 5 shipments worth $195.4K.

How Does Micro Labs Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MSN LABORATORIES PRIVATE LIMITED	$2.3M	89	13	$25.9K
4	MICRO LABS LIMITED ★	$2.3M	86	14	$26.5K
3	EUGIA PHARMA SPECIALITIES LIMITED	$1.9M	39	1	$50.0K
5	AJANTA PHARMA LIMITED	$1.4M	112	11	$12.4K

Micro Labs Limited ranks #4 among 336 Indian Moxifloxacin exporters. Average shipment value of $26.5K compared to the market average of $42.4K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on Micro Labs Limited's Moxifloxacin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.

The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)

Micro Labs Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)

However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 91 individual customs records matching Micro Labs Limited exporting Moxifloxacin, covering 60 formulations to 15 countries via 31 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Micro Labs Limited — Moxifloxacin Exporter Profile

Micro Labs Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does Micro Labs Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from Micro Labs Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does Micro Labs Limited Contribute?

What Is the Average Shipment Value for Micro Labs Limited's Moxifloxacin Exports?

How Does Micro Labs Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does Micro Labs Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

Nigeria — NAFDAC

Germany — BfArM/EMA

How Does Micro Labs Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Moxifloxacin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Micro Labs Limited's Moxifloxacin Exports

Micro Labs Limited — Regulatory Compliance & Quality Standards

About Micro Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from Micro Labs Limited

Moxifloxacin Stats

Company Overview

Top Products by Micro Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source